Related Experiment Videos
From natural to synthetic multisite thrombin inhibitors
A Lombardi1, G De Simone, S Galdiero
1Centro Interuniversitario di Ricerca sui Peptidi Bioattivi, University of Napoli Federico II, Italy.
Biopolymers
|June 25, 1999
Summary
Natural thrombin inhibitors from leeches offer potent and selective drug leads. Understanding their structure-activity relationships aids in developing novel synthetic inhibitors like hirunorms.
Area of Science:
- Biochemistry
- Pharmacology
- Structural Biology
Background:
- Natural products, particularly from leech saliva, yield potent and selective thrombin inhibitors.
- These natural inhibitors exhibit minimal cross-reactivity with other serine proteinases, making them valuable drug development templates.
- Understanding their mechanism of action is crucial for designing new synthetic therapeutics.
Purpose of the Study:
- To review natural and synthetic multisite thrombin inhibitors with detailed structural information.
- To present a novel approach for developing synthetic, multisite-directed thrombin inhibitors.
- To design hirunorms mimicking the binding mode of the natural inhibitor hirudin.
Main Methods:
- Review of existing literature on natural and synthetic thrombin inhibitors.
- Detailed structural analysis of inhibitor-thrombin complexes.
- Structure-based drug design approach to develop novel synthetic inhibitors.
Main Results:
- Comprehensive review of structurally characterized natural and synthetic thrombin inhibitors.
- Development of a new class of synthetic inhibitors, hirunorms.
- Hirunorms are designed to replicate the specific binding interactions of hirudin.
Conclusions:
- Natural thrombin inhibitors provide a strong foundation for synthetic drug design.
- Detailed structural insights enable the creation of highly specific and potent therapeutic agents.
- The development of hirunorms represents a promising advancement in synthetic anticoagulant drug discovery.